المؤلفون: Eronen, Heli, Kolehmainen, Sara, Koffert, Jukka, Koskinen, Inka, Oksanen, Pia, Jussila, Airi, Huhtala, Heini, Sipponen, Taina, Ilus, Tuire

المساهمون: Faculty of Medicine, University of Helsinki, Clinicum, Gastroenterologian yksikkö, HUS Abdominal Center

مصطلحات موضوعية: Inflammatory bowel disease, dual biological therapy, combining biological therapies, adalimumab, golimumab, vedolizumab, ustekinumab, EVIDENCE-BASED CONSENSUS, CROHNS-DISEASE, ULCERATIVE-COLITIS, CLINICAL-COURSE, MANAGEMENT, DIAGNOSIS, SAFETY, General medicine, internal medicine and other clinical medicine

وصف الملف: application/pdf

Relation: This work is supported by Emil Aaltosen Saatio; Eronen , H , Kolehmainen , S , Koffert , J , Koskinen , I , Oksanen , P , Jussila , A , Huhtala , H , Sipponen , T & Ilus , T 2022 , ' Combining biological therapies in patients with inflammatory bowel disease : a Finnish multi-centre study ' , Scandinavian Journal of Gastroenterology , vol. 57 , no. 8 , pp. 936-941 . https://doi.org/10.1080/00365521.2022.2045350; ORCID: /0000-0002-8069-5273/work/116877516; http://hdl.handle.net/10138/346623; f6a144ec-f5a4-4f96-b75c-099f648ef804; 000764026100001

الاتاحة: http://hdl.handle.net/10138/346623